Business Description
Item 9 Labs Corp
NAICS : 325412
SIC : 2834
ISIN : US46564C1045
Description
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | -1.73 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.03 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.6 | |||||
| 3-Year EBITDA Growth Rate | -18.1 | |||||
| 3-Year EPS without NRI Growth Rate | -52.5 | |||||
| 3-Year FCF Growth Rate | 17.5 | |||||
| 3-Year Book Growth Rate | 75.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.49 | |||||
| 9-Day RSI | 29.11 | |||||
| 14-Day RSI | 35.09 | |||||
| 6-1 Month Momentum % | -96.42 | |||||
| 12-1 Month Momentum % | -99.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.02 | |||||
| Days Inventory | 96.54 | |||||
| Days Sales Outstanding | 12.4 | |||||
| Days Payable | 239.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.3 | |||||
| Shareholder Yield % | -23830 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.8 | |||||
| Operating Margin % | -51.01 | |||||
| Net Margin % | -157.62 | |||||
| FCF Margin % | -13.19 | |||||
| ROE % | -49.87 | |||||
| ROA % | -27.12 | |||||
| ROIC % | -7.09 | |||||
| ROC (Joel Greenblatt) % | -87.54 | |||||
| ROCE % | -31.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.58 | |||||
| EV-to-EBITDA | -1.72 | |||||
| EV-to-Revenue | 1.73 | |||||
| EV-to-FCF | -13.14 | |||||
| Earnings Yield (Greenblatt) % | -63.29 | |||||
| FCF Yield % | -25980 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INLB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Item 9 Labs Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 19.69 | ||
| EPS (TTM) ($) | -0.32 | ||
| Beta | 0.38 | ||
| Volatility % | 106.08 | ||
| 14-Day RSI | 35.09 | ||
| 14-Day ATR ($) | 0.000098 | ||
| 20-Day SMA ($) | 0.000272 | ||
| 12-1 Month Momentum % | -99.68 | ||
| 52-Week Range ($) | 0.0001 - 0.1 | ||
| Shares Outstanding (Mil) | 102.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Item 9 Labs Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Item 9 Labs Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Item 9 Labs Corp Frequently Asked Questions
What is Item 9 Labs Corp(INLB)'s stock price today?
The current price of INLB is $0.00. The 52 week high of INLB is $0.10 and 52 week low is $0.00.
When is next earnings date of Item 9 Labs Corp(INLB)?
The next earnings date of Item 9 Labs Corp(INLB) is 2024-04-25 Est..
Does Item 9 Labs Corp(INLB) pay dividends? If so, how much?
Item 9 Labs Corp(INLB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers